MedCap AB (OSTO:MCAP) Ending Cash Position: kr286 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MCAP MedCap AB OSTO:MCAP
76 GF Score
Price kr533.00
GF Value kr573.86
Valuation Fairly Valued
View Full Analysis

What is MedCap AB Ending Cash Position?

MedCap AB OSTO:MCAP +0.95% 76 Ending Cash Position is kr286 Mil as of Jun. 2026. GuruFocus rates OSTO:MCAP with a GF Score™ of 76/100 and a GF Value™ of kr573.86 (Fairly Valued).

MedCap AB's Ending Cash Position for the quarter that ended in Jun. 2026 was kr286 Mil.

MedCap AB's quarterly Ending Cash Position increased from Dec. 2025 (kr370 Mil) to Mar. 2026 (kr394 Mil) but then declined from Mar. 2026 (kr394 Mil) to Jun. 2026 (kr286 Mil).

MedCap AB's annual Ending Cash Position increased from Dec. 2023 (kr188 Mil) to Dec. 2024 (kr370 Mil) and increased from Dec. 2024 (kr370 Mil) to Dec. 2025 (kr370 Mil).

MedCap AB Ending Cash Position Related Terms

MedCap AB Ending Cash Position Historical Data

* Premium members only.

The historical data trend for MedCap AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedCap AB Ending Cash Position Chart

MedCap AB Annual Data
Trend Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 139.70 236.20 188.20 370.10 370.40

MedCap AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 335.10 358.70 370.40 394.40 286.30
OSTO:MCAP
76GF Score
MedCap AB OSTO:MCAP
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedCap AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

MedCap AB's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=370.2+0.19999999999997
=370

MedCap AB's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=394+-107.7
=286

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of kr286 Mil mean?
MedCap AB (OSTO:MCAP) has a Ending Cash Position of kr286 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on MedCap AB and its competitors.
Is MedCap AB's Ending Cash Position too high?
MedCap AB's current Ending Cash Position is kr286 Mil. Overall, MedCap AB has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MedCap AB's Ending Cash Position compare to ABT and SYK?
MedCap AB's Ending Cash Position of kr286 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on MedCap AB and its competitors. MedCap AB's current Ending Cash Position is kr286 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedCap AB stock overvalued right now?
Based on GuruFocus' analysis, MedCap AB (OSTO:MCAP) is currently considered Fairly Valued. The stock's GF Value™ is kr573.86, compared to a current price of kr533.00 — trading 7.1% below its estimated fair value. The current Ending Cash Position is kr286 Mil. MedCap AB's overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For MedCap AB (OSTO:MCAP), the current Ending Cash Position is kr286 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MedCap AB (OSTO:MCAP) Overvalued in 2026?

Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued. The current stock price of kr533.00 is trading 7.1% below its estimated GF Value™ of kr573.86. GuruFocus considers MedCap AB to be Fairly Valued.

Key valuation signals for OSTO:MCAP:

  • Ending Cash Position: kr286 Mil
  • GF Value™: kr573.86 vs. price of kr533.00 (7.1% below fair value)
  • GF Score™: 76/100

No single metric tells the full story. See the OSTO:MCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MedCap AB Business Description

Other Exchanges MCAPs:UK61MA:Germany
Address Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
76GF Score

Get the complete analysis for OSTO:MCAP

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr533.00
Price
kr573.86
GF Value